Detalhe da pesquisa
1.
Organoid cultures derived from patients with advanced prostate cancer.
Cell
; 159(1): 176-187, 2014 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-25201530
2.
Do Phosphodiesterase Type 5 Inhibitors Increase the Risk of Biochemical Recurrence After Radical Prostatectomy?
J Urol
; 211(3): 400-406, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38194487
3.
Predictive value of kallikrein forms and ß-microseminoprotein in blood from patients with evidence of detectable levels of PSA after radical prostatectomy.
World J Urol
; 41(6): 1489-1495, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37209144
4.
MRI-guided focused ultrasound focal therapy for patients with intermediate-risk prostate cancer: a phase 2b, multicentre study.
Lancet Oncol
; 23(7): 910-918, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35714666
5.
Have urinary function outcomes after radical prostatectomy improved over the past decade?
Cancer
; 128(5): 1066-1073, 2022 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34724196
6.
Independent validation of a pre-specified four-kallikrein marker model for prediction of adverse pathology and biochemical recurrence.
Br J Cancer
; 126(7): 1004-1009, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34903844
7.
Oncologic Outcomes of Total Length Gleason Pattern 4 on Biopsy in Men with Grade Group 2 Prostate Cancer.
J Urol
; 208(2): 309-316, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35363038
8.
Association of Family History of Cancer with Clinical and Pathological Outcomes for Prostate Cancer Patients on Active Surveillance.
J Urol
; 208(2): 325-332, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35377777
9.
Characterization of Symptoms after Radical Prostatectomy and Their Relation to Postoperative Complications.
J Urol
; 207(2): 367-374, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34544264
10.
Clinical utility of subclassifying positive surgical margins at radical prostatectomy.
BJU Int
; 129(2): 194-200, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34161656
11.
Morbidity of salvage radical prostatectomy: limited impact of the minimally invasive approach.
World J Urol
; 40(7): 1637-1644, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35596018
12.
A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomy.
Br J Cancer
; 123(4): 604-609, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32467601
13.
Extensive disease among potential candidates for hemi-ablative focal therapy for prostate cancer.
Int J Urol
; 27(2): 179-185, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31833113
14.
Clinical Usefulness of Total Length of Gleason Pattern 4 on Biopsy in Men with Grade Group 2 Prostate Cancer.
J Urol
; 201(1): 77-82, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30076908
15.
Clinical Usefulness of Prostate and Tumor Volume Related Parameters following Radical Prostatectomy for Localized Prostate Cancer.
J Urol
; 201(3): 535-540, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30300632
16.
Development of Nomograms to Predict the Recovery of Erectile Function Following Radical Prostatectomy.
J Sex Med
; 16(11): 1796-1802, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31521569
17.
Comparative effectiveness of radical prostatectomy with adjuvant radiotherapy versus radiotherapy plus androgen deprivation therapy for men with advanced prostate cancer.
Cancer
; 124(20): 4010-4022, 2018 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30252932
18.
Molecular Profiles of Prostate Cancer: To Treat or Not to Treat.
Annu Rev Med
; 67: 119-35, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26515982
19.
Randomized Trial of Partial Gland Ablation with Vascular Targeted Phototherapy versus Active Surveillance for Low Risk Prostate Cancer: Extended Followup and Analyses of Effectiveness.
J Urol
; 200(4): 786-793, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29864437
20.
Biopsy Core Features are Poor Predictors of Adverse Pathology in Men with Grade Group 1 Prostate Cancer.
J Urol
; 199(4): 961-968, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29030317